参考文献/References:
[1] 张国振,何庆.活性氧对高原性肺动脉高压的影响[J].心血管病学进展,2018,39(4):576-579.
[2] Amsellem V,Abid S,Poupel L,et al.Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 chemokine systems in hypoxic pulmonary hypertension [J].Am J Respir Cell Mol Biol,2017,56(5):597-608.
[3] 王领,赵一蔚,任培乐,等.FKN浓度对人脐静脉内皮细胞中CX3CR1表达的影响[J].新疆医科大学学报,2018,41(4):468-471.
[4] Liu W,Liang Y,Chan Q,et al.CX3CL1 promotes lung cancer cell migration and invasion via the Src/focal adhesion kinase signaling pathway[J].Oncol Rep,2019,41(3):1911-1917.
[5] Fernandez-Prieto M,Fernandez-Acenero MJ,Lopez-Palacios N,et al.CX3CL1-CX3CR1 axis:a new player in coeliac disease pathogenesis [J].Nutrients,2019,11(11):2551.
[6] Yang XP,Mattagajasingh S,Su S,et al.Fractalkine upregulates intercellular adhesion molecule-1 in endothelial cells through CX3CR1 and the Jak Stat5 pathway [J].Circ Res,2007,101(10):1001-1008.
[7] Zhang J,Hu H,Palma NL,et al.Hypoxia-induced endothelial CX3CL1 triggers lung smooth muscle cell phenotypic switching and proliferative expansion [J].Am J Physiol Lung Cell Mol Physiol,2012,303(10):L912-L922.
[8] 王艳霞.AECs在低氧性肺动脉高压中的作用及机制研究[D].中国人民解放军空军军医大学,2018.
[9] Galie N,McLaughlin VV,Rubin LJ,et al.An overview of the 6th world symposium on pulmonary hypertension[J].Eur Respir J,2019,53(1):1802148.
[10] Strange G,Playford D,Stewart S,et al.Pulmonary hypertension:prevalence and mortality in the armadale echocardiography cohort [J].Heart,2012,98(24):1805-1811.
[11] Simonneau G,Montani D,Celermajer DS,et al.Haemodynamic definitions and updated clinical classification of pulmonary hypertension[J].Eur Respir J,2019,53(1):1801913.
[12] Gall H,Felix JF,Schneck FK,et al.The giessen pulmonary hypertension registry:survival in pulmonary hypertension subgroups[J].J Heart Lung Transplant,2017,36(9):957-967.
[13] Hurdman J,Condliffe R,Elliot CA,et al.Pulmonary hypertension in COPD:results from the ASPIRE registry[J].Eur Respir J,2013,41(6):1292-1301.
[14] Wilkins MR,Ghofrani HA,Weissmann N,et al.Pathophysiology and treatment of high-altitude pulmonary vascular disease[J].Circulation,2015,131(6):582-590.
[15] Mason RJ.Biology of alveolar pulmonary cells[J].Respirology,2006,11 Suppl:S12-15.
[16] Serrano-Mollar A,Gay-Jordi G,Guillamat-Prats R,et al.Safety and tolerability of alveolar pulmonary cell transplantation in idiopathic pulmonary fibrosis [J].Chest,2016,150(3):533-543.
[17] Oczypok EA,Perkins TN,Oury TD.Alveolar epithelial cell-derived mediators:potential direct regulators of large airway and vascular responses [J].Am J Respir Cell Mol Biol,2017,56(6):694-699.
[18] Umehara H,Bloom E,Okazaki T,et al.Fractalkine and vascular injury[J].Trends Immunol,2001,22(11):602-607.
[19] Singh SK,Mishra MK,Singh R.Hypoxia-inducible factor-1alpha induces CX3CR1 expression and promotes the epithelial to mesenchymal transition (EMT) in ovarian cancer cells[J].J Ovarian Res,2019,12(1):42.
[20] McDermott DH,Colla JS,Kleeberger CA,et al.Genetic polymorphism in CX3CR1 and risk of HIV disease [J].Science,2000,290(5499):2031.
[21] Lesnik P,Haskell CA,Charo IF.Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis[J].J Clin Invest,2003,111(3):333-340.
[22] Zhang X,Feng X,Cai W,et al.Chemokine CX3CL1 and its receptor CX3CR1 are associated with human atherosclerotic lesion volnerability [J].Thromb Res,2015,135(6):1147-1153.
[23] 陈小菊,程德云,樊莉莉.低氧对大鼠PASMCs和肺微血管内皮细胞表达及分泌Fractalkine的影响[J].四川大学报(医学版),2012,43(5).661-665.